Cross-modality fusion of hematology-based digital and molecular biomarkers for intelligent epidemiological screening and surveillance of hepatocellular carcinoma.

Early detection of hepatocellular carcinoma (HCC) remains a critical challenge due to the disease's complexity and the limitations of current screening and surveillance methods, which are often invasive, costly, or lack adequate sensitivity. There is…

Preview only. Read the full abstract at the source